
Overview
Christopher Lawlor, MD, is an Atlantic Medical Group physician and the Division Chief of Pediatric Hematology and Oncology for the Valerie Fund Children’s Center. Board-certified in pediatrics and pediatric hematology/oncology by the American Board of Pediatrics, and fellowship-trained in pediatric hematology and oncology, he specializes in blood disorders and cancers in children, adolescents, and young adults, treating children of all ages with benign and malignant disease.Dr. Lawlor has spent over 25 years dedicated to children and helping them overcome serious illness so that they can grow into healthy adults. Prior to coming to Atlantic Medical Group, he served as the medical director for Pediatric Specialists of Virginia Center for Cancer and Blood Disorders and was affiliated with prestigious Children’s National Hospital in the Washington, DC, area. In his accomplished career he has managed the unique needs of infants, children, adolescents, and young adults while employing the latest innovations and breakthroughs to help children with cancer and blood disorders. From diagnosis through recovery, Dr. Lawlor provides family- and child-centered care, ensuring that patients and families receive the supportive services necessary to help them through a critical illness. In addition, he is committed to long-term follow-up care, promoting ongoing health and wellness for pediatric cancer survivors. Dr. Lawlor has collaborated on research in pediatric cancer treatment, authored book chapters, and presented nationally and internationally on many aspects of pediatric hematology and oncology. He is a member of the Children’s Oncology Group and the Histiocyte Society.After earning his medical degree from New York Medical College, Dr. Lawlor completed both his residency and a fellowship in pediatric hematology and oncology at Children’s National Medical Center, Washington, DC, one of the top five children’s hospitals in the nation. He has been listed as a top doctor by the Washingtonian and Northern Virginia Magazine. Dr. Lawlor is a participating provider of the Atlantic Accountable Care Organization.
Dr. Lawlor is rated as an Experienced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Acute Lymphoblastic Leukemia (ALL), Osteosarcoma, Ewing Sarcoma, and Immune Thrombocytopenic Purpura (ITP).
His clinical research consists of co-authoring 2 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Insurance
Accepted insurance can change. Please verify directly with the provider.
Accepted insurance plans:
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- EPO
- HMO
- EPO
- HMO
- POS
- PPO
- EPO
- HMO
- PPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- OTHER COMMERCIAL
- OTHER MEDICARE PART D
- POS
- EPO
- POS
- HMO
- INDEMNITY
- POS
- PPO
- EPO
- POS
- PPO
- MEDICARE SNP
- OTHER MEDICAID
- STATE MEDICAID
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE PART D
- EPO
- HMO
- PPO
- EPO
- HMO
- POS
- PPO
- EPO
- PPO
- EPO
- HMO
- INSURANCE PLAN
- MANAGED MEDICAID PLAN
- MEDICARE MAPD
- MEDICARE PDP
- MEDICARE SNP
- MEDICARE-MEDICAID PLAN
- OTHER MEDICARE
- OTHER MEDICARE PART D
Locations
100 Madison Avenue, Floor 3, Morristown, NJ 07960
Additional Areas of Focus
Dr. Lawlor has provided the following conditions as areas of focus. Please note that we may not have enough data to validate their experience in some of these conditions.
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
James Bussel is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Bussel is rated as a Distinguished provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). His top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Blood Clots, Anemia, Hemolysis, and Splenectomy.
Trustees Of Columbia University In The City Of New York
Cindy Neunert is a Pediatric Hematologist Oncology provider in New York, New York. Dr. Neunert is rated as a Distinguished provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Blood Clots, Sickle Cell Disease, Multisystem Inflammatory Syndrome in Children (MIS-C), and Splenectomy.
Shipra Kaicker is a Pediatric Hematologist Oncology provider in Brooklyn, New York. Dr. Kaicker is rated as an Advanced provider by MediFind in the treatment of Immune Thrombocytopenic Purpura (ITP). Her top areas of expertise are Immune Thrombocytopenic Purpura (ITP), Blood Clots, Non-Langerhans-Cell Histiocytosis, and Evans Syndrome.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Acute Lymphoblastic Leukemia (ALL)Dr. Lawlor isExperienced. Learn about Acute Lymphoblastic Leukemia (ALL).
- Ewing SarcomaDr. Lawlor isExperienced. Learn about Ewing Sarcoma.
- OsteosarcomaDr. Lawlor isExperienced. Learn about Osteosarcoma.
